Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Trevi Therapeutics, Inc. - Common Stock (NQ:TRVI)

13.03 +0.20 (+1.56%)
Delayed Quote Updated: 11:07 AM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Trevi Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Top movers in Monday's pre-market session ↗
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Dow Tumbles 200 Points; Liquidity Services Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
Trevi Therapeutics: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Outlook For Trevi Therapeutics ↗
 
Via Benzinga
News headline image
Trevi Therapeutics's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Gold Falls Sharply; Adobe Shares Dip After Weak Revenue Outlook ↗
 
Via Benzinga
News headline image
Nasdaq Down 50 Points; US Initial Jobless Claims Rise ↗
 
Via Benzinga
News headline image
Why Is Cough-Focused Trevi Therapeutics Stock Skyrocketing On Thursday? ↗
Trevi Therapeutics' CORAL trial progresses unchanged after a positive SSRE review, with topline results for chronic cough in IPF expected by mid-2025. 
Via Benzinga
News headline image
Why Trevi Therapeutics Could Be a Triple-Bagger Biotech Stock
Wall Street analysts see big potential upside for small-cap biopharma firm Trevi Therapeutics. So, what does the firm do and how does it stand out? 
Via MarketBeat
News headline image
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q2 2024 ↗
TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Recap: Trevi Therapeutics Q1 Earnings ↗
 
Via Benzinga
News headline image
Earnings Preview: Trevi Therapeutics ↗
 
Via Benzinga
News headline image
Earnings Outlook For Trevi Therapeutics ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024 ↗
TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023 ↗
TRVI stock results show that Trevi Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For March 20, 2024 ↗
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million. 
Via Benzinga
News headline image
Earnings Scheduled For November 9, 2023 ↗
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 10, 2023 ↗
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
News headline image
Earnings Scheduled For May 11, 2023 ↗
Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 16, 2023 ↗
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 ↗
 
Via Benzinga
News headline image
Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studies for Its Investigational Oral Therapy Haduvio(TM) with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - January 25, 2023) - The Stock Day Podcast welcomed Trevi Therapeutics, Inc. (NASDAQ: TRVI) ("the Company"),... 
Via Newsfile
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.